Immunological responses and epitope mapping by tuberculosis-associated antigens within the RD1 region in Japanese patients

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Nagai, Hideaki ^a   Suzukawa, Maho ^a   Sakakibara, Yumi ^b   Ohta, Ken ^a   Reche, Pedro A ^c   Suzuki, Koichi ^b   Hoshino, Yoshihiko ^b  

^a TOKYO NATIONAL HOSPITAL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BCG VACCINE; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; EPITOPE; HLA ANTIGEN CLASS 2; HLA DRB1 ANTIGEN; KILLER CELL LECTIN LIKE RECEPTOR G1; NATURAL KILLER CELL RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR; TETRAMER; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; GAMMA INTERFERON; PEPTIDE;

ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; HLA SYSTEM; HUMAN; HUMAN CELL; IMAGING SYSTEM; IMMUNE RESPONSE; IMMUNOASSAY; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; PHENOTYPE; POPULATION RESEARCH; PROTEIN EXPRESSION; QUANTIFERON TB GOLD IN TUBE ASSAY; TUBERCULOSIS; ADULT; AGED; AMINO ACID SEQUENCE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; FEMALE; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; LUNG TUBERCULOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MYCOBACTERIUM TUBERCULOSIS; PATHOLOGY;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; TUBERCULOSIS, PULMONARY;

EID: 84907899285     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/764028     Document Type: Article

References (32)

1. World Health Organization, "Global Tuberculosis Report 2012," Tech.Rep., 2012, http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502-eng.pdf.
2. P. E. M. Fine, "Variation in protection by BCG: implications of and for heterologous immunity," The Lancet, vol. 346, no. 8986, pp. 1339-1345, 1995.
3. G. A. MacGregor, "BCG: bad news from India," The Lancet, vol. 1, no. 8163, pp. 73-74, 1980.
4. P. D. Hart and I. Sutherland, "BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Final report to the Medical Research Council," British Medical Journal, vol. 2, no. 6082, pp. 293-295, 1977.
5. World Health Organization, "BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life," Bulletin of the World Health Organization, vol. 46,no. 3, pp. 371-385, 1972.
6. G. S. Tomlinson, T. J. Cashmore, P.T.G. Elkington et al., "Transcriptional profiling of innate and adaptive human immune responses tomycobacteria in the tuberculin skin test," European Journal of Immunology, vol. 41, no. 11, pp. 3253-3260, 2011.
7. C. M. Denkinger, K. Dheda, and M. Pai, "Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?" Clinical Microbiology and Infection, vol. 17, no. 6, pp. 806-814, 2011.
8. I. Brock, K.Weldingh, E.M. S. Leyten, S.M. Arend, P.Ravn, and P. Andersen, "Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection," Journal of Clinical Microbiology, vol. 42, no. 6, pp. 2379-2387, 2004.
9. S. M. Arend, P. Andersen, K. E. van Meijgaarden et al., "Detection of active tuberculosis infection by T cell responses to early- secreted antigenic target 6-kDa protein and culture filtrate protein 10," Journal of Infectious Diseases, vol. 181, no. 5, pp. 1850-1854, 2000.
10. S. M. Arend, A. Geluk, K. E. van Meijgaarden et al., "Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides," Infection and Immunity, vol. 68, no. 6, pp. 3314-3321, 2000.
11. Oxford Immunotec, "T-SPOT.TB Overview," 2012, http://www.oxfordimmunotec.com/T-SPOT.TB-Overview-North-America.
12. T. Matsumoto, Y. Hirayama, Y. Hisamitsu et al., "Simultaneous and longitudinal comparison of interferon gamma release assay data from health care workers in Japan," Journal of Mycobacterial Diseases, vol. 3, p. 134, 2013.
13. C. Aagaard, I. Brock, A. Olsen, T. H.M. Ottenhoff, K. Weldingh, and P. Andersen, "Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacteriumtuberculosis complex," Journal of Infectious Diseases, vol. 189, no. 5, pp. 812-819, 2004.
14. C. S. Arlehamn, J. Sidney, and R.Henderson, "Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ)," Journal of Immunology, vol. 188, no. 10, pp. 5020-5031, 2012.
15. H. Ariga, H. Nagai, and A. Kurashima, "Stratified threshold values of quantiFERON assay for diagnosing tuberculosis infection in immunocompromised populations," Tuberculosis Research and Treatment, vol. 2011, Article ID 940642, 9 pages, 2011.
16. A. Nakanishi, S. Imajoh-Ohmi, and F. Hanaoka, "Characterization of the interaction between DNA gyrase inhibitor and DNA gyrase of Escherichia coli," Journal of Biological Chemistry, vol. 277, no. 11, pp. 8949-8954, 2002.
17. Y. Itoh, N. Mizuki, T. Shimada et al., "High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population," Immunogenetics, vol. 57, no. 10, pp. 717-729, 2005.
18. K. Komiya, H. Ariga, H. Nagai et al., "Impact of peripheral lymphocyte count on the sensitivity of 2 IFN-γ release assays, QFT-Gand ELISPOT, in patients with pulmonary tuberculosis," Internal Medicine, vol. 49, no. 17, pp. 1849-1855, 2010.
19. I. Marcolino, G. K. Przybylski, M. Koschella et al., "Frequent expression of the natural killer cell receptor KLRG1 in human cord blood T cells: correlation with replicative history," European Journal of Immunology, vol. 34, no. 10, pp. 2672-2680, 2004.
20. Y. Yamashita, Y. Hoshino, and M. Oka, "Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigens," Japanese Journal of Infectious Diseases, vol. 66, no. 3, pp. 207-215, 2013.
21. V. Rozot, S. Vigano, and J. Mazza-Stalder, "Mycobacterium tuberculosis-specific CD8(+) T cells are functionally and phenotypically different between latent infection and active disease," European Journal of Immunology, vol. 43, no. 6, pp. 1568-1577, 2013.
22. A. M. Gallegos, E. G. Pamer, and M. S. Glickman, "Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection," Journal of Experimental Medicine, vol. 205, no. 10, pp. 2359-2368, 2008.
23. N. Caccamo, G. Guggino, S. A. Joosten et al., "Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection," European Journal of Immunology, vol. 40, no. 8, pp. 2211-2220, 2010.
24. P. A. Reche, J. P. Glutting, H. Zhang, and E. L. Reinherz, "Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles," Immunogenetics, vol. 56, no. 6, pp. 405-419, 2004.
25. P. A. Reche and E. L. Reinherz, "Prediction of peptide-MHC binding using profiles," Methods in Molecular Biology, vol. 409, pp. 185-200, 2007.
26. P. A. Reche and E. L. Reinherz, "Definition of MHC supertypes through clustering of MHC peptide-binding repertoires," Methods in Molecular Biology, vol. 409, pp. 163-173, 2007.
27. W.W. Reiley, S. Shafiani, S. T.Wittmer et al., "Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19408-19413, 2010.
28. D. Goletti, C. Stefania, O. Butera et al., "Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-study," PLoS ONE, vol. 3, no. 10, Article ID e3417, 2008.
29. A. Lalvani, "Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy," Chest, vol. 131, no. 6, pp. 1898-1906, 2007.
30. M. Pai, A. Zwerling, and D. Menzies, "Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update," Annals of Internal Medicine, vol. 149, no. 3, pp. 177-184, 2008.
31. A. J.Wolf, L.Desvignes, B. Linas et al., "Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs," Journal of Experimental Medicine, vol. 205, no. 1, pp. 105-115, 2008.
32. T. Lindenstrom, N. P. Knudsen, and E. M. Agger, "Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG1-IL-2-secreting central memory cells," European Journal of Immunology, vol. 190, no. 12, pp. 6311-6319, 2013.